INTELLIPHARMACEUTICS INTERNATIONAL INC. UNDERWRITING AGREEMENTUnderwriting Agreement • October 12th, 2018 • Intellipharmaceutics International Inc. • Pharmaceutical preparations • New York
Contract Type FiledOctober 12th, 2018 Company Industry JurisdictionThe undersigned, Intellipharmaceutics International Inc., a corporation formed under the laws of Canada (collectively with its subsidiaries and affiliates, including, without limitation, all entities disclosed or described in the Registration Statement (as hereinafter defined) as being subsidiaries or affiliates of Intellipharmaceutics International Inc. (the “Company”)), hereby confirms its agreement (this “Agreement”) with H.C. Wainwright & Co., LLC (hereinafter referred to as “you” (including its correlatives) or the “Underwriter”) as follows:
COMMON SHARE PURCHASE WARRANT INTELLIPHARMACEUTICS INTERNATIONAL INC.Common Share Purchase Warrant • October 12th, 2018 • Intellipharmaceutics International Inc. • Pharmaceutical preparations • New York
Contract Type FiledOctober 12th, 2018 Company Industry JurisdictionTHIS COMMON SHARE PURCHASE WARRANT (the “Warrant”) certifies that, for value received, _____________ or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date hereof (the “Initial Exercise Date”) and on or prior to 5:00 p.m. (New York City time) on ______________1 (the “Termination Date”) but not thereafter, to subscribe for and purchase from Intellipharmaceutics International Inc., a Canadian corporation (the “Company”), up to ______ Common Shares (as subject to adjustment hereunder, the “Warrant Shares”). The purchase price of one Common Share under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b). This Warrant is issued pursuant to the Registration Statement which Registration Statement also registers the Warrant Shares issuable upon exercise of this Warrant.
PRE-FUNDED COMMON SHARE PURCHASE WARRANT INTELLIPHARMACEUTICS INTERNATIONAL INC.Pre-Funded Common Share Purchase Warrant • October 12th, 2018 • Intellipharmaceutics International Inc. • Pharmaceutical preparations • New York
Contract Type FiledOctober 12th, 2018 Company Industry JurisdictionTHIS PRE-FUNDED COMMON SHARE PURCHASE WARRANT (the “Warrant”) certifies that, for value received, _____________ or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date hereof (the “Initial Exercise Date”) and until this Warrant is exercised in full (the “Termination Date”), to subscribe for and purchase from Intellipharmaceutics International Inc., a Canadian corporation (the “Company”), up to ______ Common Shares (as subject to adjustment hereunder, the “Warrant Shares”). The purchase price of one Common Share under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b). This Warrant is issued pursuant to the Registration Statement which Registration Statement also registers the Warrant Shares issuable upon exercise of this Warrant.
UNDERWRITER COMMON SHARE PURCHASE WARRANT INTELLIPHARMACEUTICS INTERNATIONAL INC.Underwriter Common Share Purchase Warrant • October 12th, 2018 • Intellipharmaceutics International Inc. • Pharmaceutical preparations • New York
Contract Type FiledOctober 12th, 2018 Company Industry JurisdictionTHIS UNDERWRITER COMMON SHARE PURCHASE WARRANT (the “Warrant”) certifies that, for value received, _____________ or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date hereof (the “Initial Exercise Date”) and on or prior to 5:00 p.m. (New York City time) on ______________1 (the “Termination Date”) but in no event after five (5) years following the effective date offering pursuant to which this Warrant is being issue in accordance with FINRA Rule 5110(f)(2)(G)(i), to subscribe for and purchase from Intellipharmaceutics International Inc., a Canadian corporation (the “Company”), up to ______ Common Shares (as subject to adjustment hereunder, the “Warrant Shares”). The purchase price of one Common Share under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b). This Warrant is issued pursuant to the Registration Statement which Registration Sta